Press release
Global Human Recombinant Insulin Market – Industry Insights
In September 2017, Biocon Limited: an India-based biopharmaceutical firm received funding from Juvenile Diabetes Research Foundation (JDRF) to study oral insulin drug candidate: Tregopil, to evaluate the safety and tolerability in people suffering with type 1 diabetes. The collaboration between Biocon and JDRF is a part of JDRF's Industry Discovery and Development Partnership (IDDP) programme, through which JDRF provides financial support to Biocon to accelerate research in type 1 diabetes management.
Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1797
Increasing Incidence of Diabetes Worldwide is expected to Drive Growth of the Human Recombinant Insulin Market
Insulin plays a vital role in diabetes management by controlling blood sugar level. Both type 1 and type 2 diabetes people are benefited by maintaining blood sugar levels. Increasing incidence of diabetes is expected to be major factor driving growth of the market in the near future. For instance, according to the World Health Organization (WHO), 2016, an estimated 422 million adults are suffering from diabetes. The major spike in incidence of type 2 diabetes over the last decade is mainly attributed to increasing prevalence of obesity. According to the International Diabetes Federation (IDF) Atlas 2017, global burden of diabetes is affecting more than 425 million people, among which one-third are older than 65 years of age. Moreover, the number of people with diabetes may rise to 629 million in 2045. Furthermore, 352 million with impaired glucose tolerance are at high risk of developing diabetes. Furthermore, continuous increase in incidence rate of diabetes, owing to unhealthy lifestyle, binge eating, obesity, overweight, physical inactivity, and insulin resistivity among global population is expected to further boost growth of the human recombinant insulin market over the forecast period.
However, high cost of insulin may restrain growth of the market, as patients from low and middle countries are unable to afford it. According to the Pharmaceutical Care Management Association (PCMA) May 2018 report, prices of insulin have increased over 10-fold since 1985 and prices have exhibited significant rise during the last past 10 years (2008 to 2018). According to PCMA, prices for Humulin/Novolin have increased from around US$ 25 per prescription in 1985 to nearly US$ 300 in 2016. Furthermore, prices for long-acting insulins have increased from around US$ 100 per prescription in 2007 to nearly US$ 400 in 2016.
Download The PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1797
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Human Recombinant Insulin Market – Industry Insights here
News-ID: 1204164 • Views: …
More Releases from Coherent Market Insights
Surgical Instrument Tracking Market Estimated to Reach USD 1,708.2 Million by 20 …
The global Surgical Instrument Tracking Market is expected to witness exponential growth, rising from USD 505.5 million in 2025 to USD 1,708.2 million by 2032, at a robust compound annual growth rate (CAGR) of 19% during the forecast period. The surge is fueled by increasing pressure to improve surgical efficiency, reduce errors, and enhance compliance with hospital regulations and sterilization standards.
Surgical instrument tracking systems use advanced technologies like RFID (radio-frequency…
Aesthetic Thread Market Analysis, Competitive Landscape, And Industry Overview 2 …
The global Aesthetic Thread Market is projected to grow from USD 147.7 million in 2025 to USD 231.0 million by 2032, representing a compound annual growth rate (CAGR) of 6.6% over the forecast period. This growth is driven by the rising demand for minimally invasive cosmetic procedures, an aging population seeking non-surgical facial rejuvenation, and ongoing innovations in thread lift technology.
Aesthetic threads, often used in thread lift procedures, are dissolvable…
Body Temperature Monitoring Market Overview, Key Drivers, Competitive Landscape, …
The global Body Temperature Monitoring Market is projected to grow from USD 1,196.5 million in 2025 to USD 1,763.8 million by 2032, representing a compound annual growth rate (CAGR) of 5.7% over the forecast period. The market is being shaped by increasing demand for continuous, contactless, and wearable temperature monitoring solutions across clinical, homecare, and public health settings.
Body temperature monitoring is a fundamental diagnostic and surveillance tool used across healthcare…
Real-world Data (RWD) Market Size Anticipated to Reach USD 6.1 Billion by 2032 , …
The global Real-world Data (RWD) Market is on a strong growth trajectory, projected to rise from USD 2.38 billion in 2025 to USD 6.1 billion by 2032, reflecting a compelling compound annual growth rate (CAGR) of 14.4%. This expansion is driven by the healthcare sector's growing emphasis on evidence-based decisions, value-based care models, and regulatory support for RWD use in drug development and post-market surveillance.
Real-world data refers to health data…
More Releases for Diabetes
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027.
Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
Global Diabetes Industry
Global Diabetes Industry
Market Insight
Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling…
Diabetes Drugs Market: Increasing Prevalence of Diabetes to Stoke Market Growth
According to the TMR report, the global diabetes drugs market stood at a valuation of US$43.1 bn in 2016 and is likely to be valued at US$58.4 bn by the end of 2025 expanding at a CAGR of 3.6% between 2017 and 2025.
Research and Development Pursuits to Introduce Novel Products Stokes Growth
The rising per capita income in several parts of world leading to changing lifestyles and adoption of unhealthy food…
